Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 923

1.

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.

Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, Pai M, Dendukuri N.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD009593. doi: 10.1002/14651858.CD009593.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;(1):CD009593.

2.

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.

Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N.

Cochrane Database Syst Rev. 2014 Jan 21;(1):CD009593. doi: 10.1002/14651858.CD009593.pub3. Review.

3.

Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.

Shah M, Hanrahan C, Wang ZY, Dendukuri N, Lawn SD, Denkinger CM, Steingart KR.

Cochrane Database Syst Rev. 2016 May 10;(5):CD011420. doi: 10.1002/14651858.CD011420.pub2. Review.

4.

The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs.

Theron G, Peter J, Richardson M, Barnard M, Donegan S, Warren R, Steingart KR, Dheda K.

Cochrane Database Syst Rev. 2014 Oct 29;(10):CD010705. doi: 10.1002/14651858.CD010705.pub2. Review.

5.

GenoType® MTBDRsl assay for resistance to second-line anti-tuberculosis drugs.

Theron G, Peter J, Richardson M, Warren R, Dheda K, Steingart KR.

Cochrane Database Syst Rev. 2016 Sep 8;9:CD010705. [Epub ahead of print] Review.

6.

Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.

Scott LE, McCarthy K, Gous N, Nduna M, Van Rie A, Sanne I, Venter WF, Duse A, Stevens W.

PLoS Med. 2011 Jul;8(7):e1001061. doi: 10.1371/journal.pmed.1001061. Epub 2011 Jul 26.

7.

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.

Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, Gler MT, Blakemore R, Worodria W, Gray C, Huang L, Caceres T, Mehdiyev R, Raymond L, Whitelaw A, Sagadevan K, Alexander H, Albert H, Cobelens F, Cox H, Alland D, Perkins MD.

Lancet. 2011 Apr 30;377(9776):1495-505. doi: 10.1016/S0140-6736(11)60438-8. Epub 2011 Apr 18.

8.

The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania.

Pimkina E, Zablockis R, Nikolayevskyy V, Danila E, Davidaviciene E.

Respir Med. 2015 Nov;109(11):1484-9. doi: 10.1016/j.rmed.2015.07.006. Epub 2015 Jul 11.

PMID:
26403251
9.

Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.

Theron G, Peter J, van Zyl-Smit R, Mishra H, Streicher E, Murray S, Dawson R, Whitelaw A, Hoelscher M, Sharma S, Pai M, Warren R, Dheda K.

Am J Respir Crit Care Med. 2011 Jul 1;184(1):132-40. doi: 10.1164/rccm.201101-0056OC. Epub 2011 Apr 14.

PMID:
21493734
10.

Evaluation of the Xpert MTB/RIF assay for diagnosis of tuberculosis and rifampin resistance in county-level laboratories in Hunan province, China.

Hu P, Bai L, Liu F, Ou X, Zhang Z, Yi S, Chen Z, Gong D, Liu B, Guo J, Tan Y.

Chin Med J (Engl). 2014;127(21):3744-50.

PMID:
25382330
11.

Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study.

van Kampen SC, Tursynbayeva A, Koptleuova A, Murzakhmetova Z, Bigalieva L, Aubakirova M, Pak S, van den Hof S.

PLoS One. 2015 Jul 16;10(7):e0132514. doi: 10.1371/journal.pone.0132514. eCollection 2015. Erratum in: PLoS One. 2015;10(8):e0136368. Murzabekova, Zauresh [corrected to Murzakhmetova, Zauresh].

13.

Diagnostic accuracy of the Xpert MTB/RIF assay for extrapulmonary and pulmonary tuberculosis when testing non-respiratory samples: a systematic review.

Maynard-Smith L, Larke N, Peters JA, Lawn SD.

BMC Infect Dis. 2014 Dec 31;14:709. doi: 10.1186/s12879-014-0709-7. Review.

14.

Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study.

Lawn SD, Brooks SV, Kranzer K, Nicol MP, Whitelaw A, Vogt M, Bekker LG, Wood R.

PLoS Med. 2011 Jul;8(7):e1001067. doi: 10.1371/journal.pmed.1001067. Epub 2011 Jul 26.

15.

Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation.

Menzies NA, Cohen T, Lin HH, Murray M, Salomon JA.

PLoS Med. 2012;9(11):e1001347. doi: 10.1371/journal.pmed.1001347. Epub 2012 Nov 20.

16.

Impact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial.

Durovni B, Saraceni V, van den Hof S, Trajman A, Cordeiro-Santos M, Cavalcante S, Menezes A, Cobelens F.

PLoS Med. 2014 Dec 9;11(12):e1001766. doi: 10.1371/journal.pmed.1001766. eCollection 2014 Dec. Erratum in: PLoS Med. 2015 Dec;12(12):e1001928.

17.

Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings.

Luetkemeyer AF, Firnhaber C, Kendall MA, Wu X, Mazurek GH, Benator DA, Arduino R, Fernandez M, Guy E, Johnson P, Metchock B, Sattler F, Telzak E, Wang YF, Weiner M, Swindells S, Sanne IM, Havlir DV, Grinsztejn B, Alland D; AIDS Clinical Trials Group A5295 and Tuberculosis Trials Consortium Study 34 Teams.

Clin Infect Dis. 2016 May 1;62(9):1081-8. doi: 10.1093/cid/ciw035. Epub 2016 Feb 2.

18.

Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia.

Mavenyengwa RT, Shaduka E, Maposa I.

Infect Dis Poverty. 2017 Jan 11;6(1):13. doi: 10.1186/s40249-016-0213-y.

19.

Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study.

Rachow A, Zumla A, Heinrich N, Rojas-Ponce G, Mtafya B, Reither K, Ntinginya EN, O'Grady J, Huggett J, Dheda K, Boehme C, Perkins M, Saathoff E, Hoelscher M.

PLoS One. 2011;6(6):e20458. doi: 10.1371/journal.pone.0020458. Epub 2011 Jun 29.

20.

Diagnostic yield of Bronchoalveolar Lavage gene Xpert in smear-negative and sputum-scarce pulmonary tuberculosis.

Khalil KF, Butt T.

J Coll Physicians Surg Pak. 2015 Feb;25(2):115-8. doi: 02.2015/JCPSP.115118.

PMID:
25703755

Supplemental Content

Support Center